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1. Introduction 
Cerebral ischemia results from the decrease in oxygen and glucose supply by the transient 
or permanent reduction of cerebral blood flow, triggering excitotoxic, oxidative, 
inflammatory and apoptotic events which end up in brain tissue death. Cerebral ischemia is 
one of the leading causes of death in industrialized countries, a medical emergency with few 
specific treatments available to minimize the acute injury and provide neuroprotection and 
brain repair. In fact, current therapies are limited to clot removal, aspirin, and 
decompressive hemicraniectomy for ischemic stroke. To date, alteplase, recombinant tissue-
type plasminogen activator (rt-PA) is the only approved therapy for acute ischemic stroke. 
A relevant concern in stroke research is that despite the increase in pharmacological studies, 
these treatments have shown to be ineffective or to cause adverse effects. Among more than 
700 drugs which have been studied and found to be effective in animal stroke models, yet 
none has been proved efficacious in clinical studies.  
The reduction of cerebral blood flow as a consequence of a thrombus or embolus occlusion 
results in brain injury with metabolic and functional deficits. The extent of damage depends 
on the severity and duration of cerebral blood flow decrease; and according to the 
remaining blood supply, an ischemic core and a penumbra area can be identified. 
The core is defined by almost complete energetic failure that ends up in necrotic cell death. 
Cells in the hypoperfused penumbra are non-functional, however, structural integrity and 
viability are retained. Experimental and medical evidence indicates that if the blood flow is 
not restored throughout reperfusion within hours, the penumbral region becomes part of 
the core. Hence, penumbra is the target to rescue since brain tissue at this region remains 
potentially viable for 16 to 48 hours, enabling clinicians to intervene and reduce post-stroke 
disability. 
In addition to medication, the development of novel and rational strategies directed to 
reduce impairments after stroke have been improved. Ischemic preconditioning, 
electroacupuncture, hypothermia and stem cell therapy are the most relevant non-
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pharmacological strategies for the management of the patient who suffers an ischemic 
stroke, which is at present, one of the most frequent diseases at adult age and the principal 
cause of disability in many countries.  
Hypothermia is considered as one of the most effective options to treat stroke patients in the 
management of the adverse events taking place in the brain. Hypothermia alters different 
events in cerebral injury including reduction in metabolic and enzymatic activity, release 
and re-uptake of glutamate, inflammation, production of reactive oxygen species, blood-
brain barrier breakdown and shift of cell death and survival pathways. Although stroke 
models vary in methodology, several laboratories have consistently shown that 
hypothermia reduces the extent of neurologic damage and improves neurologic function.  
The aim of this chapter is to provide a recent review of basic research in hypothermia 
treatment. Beside the clinical studies that incorporate hypothermia, numerous efforts have 
been performed in recent years to understand the mechanisms underlying protection by 
hypothermia. The clinical and basic research concurrence will allow a better understanding 
of hypothermia mechanisms in the near future, making its incorporation more efficient as a 
co-adyuvant in stroke treatment.  
2. Protective hypothermia  
The reduction of body temperature or hypothermia during an adverse event such as cardiac 
arrest, cardiopulmonary resuscitation (Hassani, 2010), neonatal hypoxia, hepatic 
encephalopathy (Barba et al., 2008) and ischemic stroke has been applied in humans as well 
as in animal models. In all cases, hypothermia has shown to preserve cerebral function. 
Clinical trials have proved that hypothermia is an effective protector of brain injury (Jacobs 
et al., 2007), and laboratory animal studies provided a considerable amount of evidence 
supporting hypothermia protection after focal, global, transient and permanent cerebral 
ischemia models as well as in vitro approaches with ischemia or hypoxia treatments (van der 
Worp et al., 2010; Yenari & Hemmen, 2010).  
The amelioration of ischemia/reperfusion-induced oxidative stress, inflammatory and 
apoptotic responses are the most promising mechanisms to understand the biological action 
of hypothermia protection. There is relevant evidence that suggests that hypothermic 
protection occurs mainly by reducing cerebral metabolism, supporting the protective effects 
of hypothermia in the different steps of the ischemic cascade as we explain below.  
2.1 Hypothermia Induction  
Mild (>32ºC) to moderate (28-32ºC) systemic hypothermia has been studied widely. It has 
been reported that mild hypothermia improves neurological function suppressing apoptosis 
pathogenesis, and moderate hypothermia limits some of the metabolic responses by altering 
neurotransmitter release, attenuating energy depletion, decreasing radical oxygen species 
production and reducing neuronal death and apoptosis.  
In clinical stroke, hypothermia is an effective neuroprotective strategy when applied for a 
long period after the ischemic event, since it has been observed that the optimum conditions 
for hypothermic neuroprotection are mostly affected by the duration and timing of cooling. 
Several works have been performed to determine the timing, duration and deepness of 
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experimental hypothermia. In gerbils subjected to a global ischemia model, the immediate 
induction or the intensification of hypothermia improved survival rate, suppressed post-
ischemic hypoperfusion and prevented vasoconstriction. However, the therapeutic 
hypothermia time window was narrow, suggesting that it should be induced immediately 
after the onset of ischemia in order to improve survival (Noguchi et al., 2011).  
There are different methods for hypothermia induction in stroke patients and in basic 
research with in vivo models of ischemia. In clinical practice, the main methods to perform 
hypothermia are surface cooling and endovascular cooling. Both methods have advantages 
and disadvantages. Surface cooling can be induced with inexpensive methods such as air 
blankets, alcohol bathing and even fans to decrease temperature. Ice packs, neck bands and 
head caps are more sophisticated and practical techniques. In addition, surface cooling can 
be performed in awake patients with ischemic stroke. It is non-expensive, non invasive and 
allows the use of hypothermia in combination with thrombolytics. In fact, the combination 
of hypothermia with intravenous tissue plasminogen activator in patients treated within 6 h 
after ischemic stroke has shown hopeful results (Hemmen et al., 2010). However, complete 
control of body temperature is not possible with surface cooling, shivering and discomfort 
of the patient may occur (reviewed in Yenari et al., 2008).  
Endovascular cooling seems to be a more efficient way to generate and control hypothermia. 
Its invasive nature leads to time loss and also requires trained personal in endovascular 
techniques (Polderman & Herold, 2009). A pilot study with patients with acute ischemic 
stroke included within 3 h after symptom onset suggests that ice cold saline infusion 
combined with pethidine and buspirone (to prevent shivering), lowered body temperature 
to 35.40.7 ºC in a fast manner and without major side effects. The results of this small 
uncontrolled case series work, suggest that the induction of hypothermia with an infusion 
represents a fast approach for induction of hypothermia that could ameliorate the damage 
caused by the delayed induction observed in the majority of clinical cases (Kollmar et al., 
2009). The authors suggest that this rapid induction of hypothermia by ice cold saline 
infusion is an effective and rapid way to induce mild to moderate hypothermia for stroke 
treatment in an ambulance car. 
The procedure to induce hypothermia also has an important effect in its neuroprotective 
effect in animal models. Recently, Wang et al (2010) reported the use of systemic, head or 
local vascular ischemia in rats with middle cerebral artery occlusion. Their results showed 
that the use of vascular cooling is the most effective procedure to reduce infarct volume as 
well as in the functional outcome rather than the other two methods (Wang et al., 2010). 
However in animal models many methods to induce hypothermia are used, including the 
removal of heating blanket with a spontaneously decrease in temperature (Doshi et al., 
2009). 
2.2 Alternative agents to induce hypothermia 
2.2.1 Helium 
Inert gases such as xenon and helium have also been used to produce hypothermia. Helium 
is considered a “cost-efficient” inert gas with no anesthetic properties, in contrast to the 
availability and cost of xenon. David et al (2009) have shown that rats subjected to transient 
middle cerebral artery occlusion and hypothermia generated by helium administered after 
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reperfusion showed an improvement in neuroprotection. Helium produces cortical 
protection evaluated by infarct size and reduction of behavioral motor deficits at 25 ºC 
hypothermia but not at 33 ºC. The post-ischemic helium hypothermia administration is 
important as a possible clinical application.  
3. Hypothermia amelioration of ischemic damage 
3.1 The ischemic cascade  
The decrease in oxygen and glucose supply by the transient or permanent reduction of 
cerebral blood flow in cerebral ischemia triggers a series of excitotoxic, oxidative, 
inflammatory and apoptotic events known as the “ischemic cascade” which ends up in brain 
tissue death. 
Brain cells are dependent almost exclusively on oxygen and glucose supply for energy 
production through oxidative phosphorylation. The oxygen and glucose reduction causes 
accumulation of lactate increasing acidosis. ATP depletion triggers a series of pathologic 
events including the loss of membrane potential, peri-infarct depolarizations, glutamate and 
aspartate excitotoxicity, the increase in Ca2+ concentration, oxidative stress and free radical 
generation, protein synthesis inhibition, inflammation and apoptosis. The disruption of ion 
homeostasis originated by the disturbance of Na+/K+-ATPase and Ca2+/H-ATPase pumps, 
and the reversed Na+-Ca2+ transporter, triggers an increase in intracellular Na+, Cl- and Ca2+ 
concentrations, as well as extracellular K+. Besides this biochemical response, within 
minutes after the onset of ischemia, there is an increase in gene expression. Cells respond to 
stress by adjusting the gene expression program in order to deal with the stress condition, to 
trigger a recovery process or to lead to signaling for additional tissue injury (Dirnalg, 1999; 
Durukan & Tatlisumak, 2007).  
3.1.1 Brain edema and blood brain barrier breakdown 
The effects of hypothermia on the disruption of the blood brain barrier have been implicated 
in many studies. The role of temperature in blood brain barrier function has been studied in 
cortex, thalamus, hippocampus and hypothalamus of rats subjected to hyperthermia. 
Astrocytic activation, a larger content of brain water, Na+, K+ and Cl- as well as structural 
abnormalities that suggest brain edema were observed, demonstrating that brain 
temperature is an important factor in regulating blood brain barrier integrity, permeability 
and brain edema (Kiyatkin & Sharma, 2009). The effect of temperature in blood brain barrier 
integrity has also been studied using hypoxia and high ambient temperature to follow the 
permeability to Na+ and the expression of the endothelial barrier antigen, a protein 
associated with blood brain barrier. A clear effect in the increase of Na+ and a reduction in 
the endothelial barrier antigen were observed, as well as an exacerbation with hyperthermia 
(Natah et al., 2009).  
The dependence of blood brain barrier integrity and brain edema with temperature has 
important implications, since even the thrombolytic therapy using rTPA is able to cause 
hemorrhagic damage. In a work by Hamann et al (2004), it has been proposed that 
hypothermia could be used as a protection to basal lamina, a component along with the 
interendothelial tight junctions and perivascular astrocytes of the blood brain barrier. Basal 
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lamina has the main function of preventing extravasation of cellular blood elements, and the 
loss of its integrity results in hemorrhage. In order to determine whether hypothermia could 
maintain microvascular integrity in ischemic stroke, the loss of collagen type IV component 
of the basal lamina, the non-cellular proteolytic system that degrades basal lamina matrix 
metalloproteinase (MMP)-2 and MMP-9, plasminogen-plasmin system urokinase-type 
plasminogen activator (uPA) and tissue-type plasminogen activator (tPA) were determined. 
Rats were subjected to 3 h ischemia and 24 h reperfusion with the suture model and 
hypothermia between 32-34ºC was applied 30 min before reperfusion. Results were 
compared with a normothermic group. This work shows that infarct size was considerably 
reduced in hypothermia treated rats; collagen type IV loss from basal lamina of cerebral 
microvessels was considerable reduced, as well as MMP-2, MMP-9, tPA and uPA activities, 
showing that hypothermia preserves microvascular integrity and reduces hemorrhage and 
the activities of MMP-2, MMP-9, uPA, and tPA (Hamman et al., 2004). 
Even that hypothermia has been successful in the protection against neuronal death in 
several models of ischemia, a recent work using C57BL/6J mice subjected to occlusion of 
bilateral common carotid arteries , demonstrated that hypothermia induced by the removal 
of heating blanket with a spontaneously decrease in temperature was an effective protection 
against neuronal death detected by histological damage and terminal deoxynucleotidyl 
transferase (TdT)-mediated dUTP-biotin nick end labeling (TUNEL). However, brain edema 
was not prevented by hypothermia treatment (Doshi et al., 2009). 
3.1.2 Metabolic downregulation 
As mentioned before, in cerebral ischemia two main regions of damage can be defined 
according to the severity and duration of the cerebral blood flow reduction: 1) The core, 
where complete abolishment of blood supply occurs (less than 12 ml/100g/min) and 2) the 
penumbra, in which collateral blood supply from surrounding arteries assures a flow of 
approximately 30 ml/100g/min. In normal non pathological conditions cerebral blood flow 
is decreased under hypothermic conditions, however, the effect of hypothermia in cerebral 
blood flow during ischemia events is not completely clear since some works support that 
hypothermia reduces or has no effect in cerebral blood flow and other reports show that it is 
increased during ischemia. Metabolic suppression has been proposed as one of the most 
relevant mechanisms underlying the hypothermic treatment. Hypothermia (in the range of 
22 to 37 ºC) reduces the rate of oxygen consumption fall in body temperature by 
approximately 5% per degree Celsius. It also decreases glucose consumption and lactate 
levels (Yenari et al., 2008).  
The deepness and extent of hypothermia stimulus has been considered of importance to the 
outcome and success of therapeutic hypothermia, and the developing methods to monitor 
and control hypothermia treatments is significant. Single voxel proton magnetic resonance 
spectroscopy (H´-MRS) is an important tool to detect metabolites and mechanisms that 
could be changing during hypothermia. Recently, using H´-MRS 7 Tesla MRI scanner, Chan 
et al (2010) determined the levels of metabolites in response to normothermia and 
hypothermia. Cortex and thalamus changes of metabolites involved in osmolality, brain 
temperature and energy metabolism were detected with important implications in the 
understanding of hypothermia protective mechanisms. For example, it was observed that 
lactate, the substrate of energy responsible for anaerobic metabolism and anaerobic 
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glycolysis increased 43% in the cortex during hypothermia. This observation has been 
considered as a change in energy metabolism associated with neuroprotection which results 
from an increase in glycolysis and depression of tricarboxilic acid cycle. 
Myo-inositol, a metabolite involved in diverse cellular processes such as signal transduction, 
membrane structure, vesicular trafficking and as an osmolite modulating cell volume, was 
increased 21 % in cortex during normothermia. They showed that this technique is able to 
detect metabolic changes in specific regions of the brain in alive animals in a noninvasively 
manner. In thalamus, taurine was 16% increased during hypothermia suggesting its role as a 
regulator of temperature and protecting neurons via its agonistic gamma-aminobutyric acid 
effect. In the same region choline decreased 29%, and authors suggest that this decrease 
could imply thermoregulation via muscarinic receptors which act against hypothermia. The 
main contribution of this work is the demonstration that this noninvasive method can detect 
changes in vivo, of significant metabolites involved in neuroprotective hypothermia (Chan et 
al., 2010).  
Using acid-base related parameters as well as the antioxidant-oxidant effects of deep (21-
22ºC) hypothermia before acute hypoxic insults in rats, it was observed that during 
hypothermia mild metabolic acidosis appeared in arterial blood. It suggests that 
hypothermia induced acidosis contributes to a reduction of potential in liver (Alva et al., 
2010). The determination of lactate levels showed that blood lactate increased in 
normothermia, and hypothermia prevents this increase contributing to the prevention of 
tissue damage.  
3.1.3 Glutamate release and peri-infarct depolarizations 
One of the critical steps in cerebral ischemia damage is excitotoxicity by glutamate and 
aspartate release as a result of membrane depolarization. The activation of glutamate 
receptors and increase in Ca2+, Na+ and Cl- levels initiate molecular events that end in cell 
death by excitotoxicity. The release of glutamate into the extracellular compartment is one of 
the early and most intense events of the ischemic cascade. The reduction of glutamate 
release in hypothermia supports the idea of protection through metabolism downregulation. 
It has been observed that the increase in glutamate levels is delayed in the ischemic core as a 
consequence of hypothermia treatment in permanent focal cerebral ischemia (Baker et al., 
1995) and the extracellular glutamate concentration is reduced in the penumbra when 
analyzed by microdialysis after permanent middle cerebral artery occlusion. This last study 
suggests that the protection observed by hypothermia probably involves a reduction in the 
pool of diffusible glutamate in the core but has little effect on glutamate release in the 
penumbra (Winfree et al., 1996). The increase in glutamate is related to the initiation of peri-
infarct depolarizations. Results using the N-methyl-D-aspartate receptor antagonist MK 801 
and moderate hypothermia (32-34 ºC) have shown neuroprotective effects alone and in 
combination supporting these observations (Alkan et al., 2001). Several studies have shown 
that hypothermia decreased glutamate efflux by attenuating the initial rise of extracelluar K+ 
and preventing Ca2+ accumulation (reviewed in Yenari et al., 2008).  
As a result of glutamate excitotoxicity, peri-infarct depolarizations contribute to the increase 
in infarct volume. The use of temporal NADH fluorescence images to obtain temporal and 
spatial resolutions to follow the propagation of peri-infarct depolarizations was performed 
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with spontaneously hypertensive rats subjected to permanent focal ischemia by occlusion of 
the middle cerebral and left common carotid arteries. Hypothermia (30ºC) maintained 2 h 
and applied before ischemia, showed that hypothermia delays the appearance, however 
does not modify the dynamics of propagation of peri-infarct depolarizations. The authors 
suggest that peri-infarct depolarizations could have a greater effect on the infarct area in 
hypothermic rats (Sasaki et al., 2009) and that the inefficacy to suppress peri-infarct 
depolarizations is the cause of the absence of hypothermia protection in several models of 
cerebral ischemia.  
3.1.4 Oxidative stress 
The generation of reactive oxygen species (ROS), reactive nitrogen species and free radicals 
is increased as a consequence of ischemic damage and particularly by the restoration of 
blood supply. Xantine oxidase, cyclooxygenase, NADPH oxidase, the mitochondrial 
respiratory chain and the inflammatory response are the major sources of free radicals in 
cerebral ischemia (Margaill et al., 2005). Reactive species play an important role in both 
necrotic and apoptotic cell death in cerebral ischemia and reperfusion. ROS generate 
oxidative stress and triggers tissue inflammation, cause damage to the cellular membrane by 
lipid peroxidation, DNA damage and disruption of cellular processes. Particularly, 
superoxide radical has an important responsibility of ischemia damage, since a number of 
ROS are derived from superoxide.  
Using an in vivo real-time quantitative superoxide analysis system with an electrochemical 
sensor previously developed, it has been demonstrated the increase in superoxide in the 
jugular veins of rats during ischemia/reperfusion in a forebrain ischemia model (Aki et al., 
2009). The effect of pre-ischemic hypothermia (32ºC) in the generation of superoxide or as a 
post ischemia treatment (immediately after reperfusion) was determined in the same model. 
Both pre and post ischemic hypothermia successfully decreased the superoxide generated 
by ischemic rats. Hypothermia also decreased oxidative stress, early inflammation and 
endothelial injury markers in both treatments (Koda et al., 2010).  
It has been observed that hypothermia maintains the glutation potential of the liver in an in 
vivo acute hypoxia model, it also avoids the increase in malondialdehide and prevents tissue 
damage induced by hypoxia (Alva et al., 2010).  
The inhibition of superoxide generation using hypothermia was also evaluated in an 
insulin-induced hypoglycemia model. They showed that intracellular accumulation of zinc 
promotes the production of ROS through NADPH oxidase activation after hypoglycemia 
(Shin et al., 2010). This work also provides evidence that hypothermia could affect other 
mechanisms such as vesicular Zn2+ release and translocation, which affects part of the 
excitotoxic neuronal death. Hypothermia prevents massive Zn2+ release which ends in cell 
death, and hyperthermia aggravates it, showing that Zn2+ release is dependent on 
temperature (Suh et al., 2004, Shin et al., 2010). However, despite all the evidences of ROS 
reduction and hypothermia protection, the determination of ROS during the first 60 minutes 
of ischemia in normothermic and hypothermic conditions using a global cerebral ischemia-
reperfusion model, showed that the widely hypothermia protection effect observed does not 
correlate with the oxidative stress induced by ROS, as observed with electron spin 
resonance system (Kunimatsu et al., 2001). The use of different ischemia models, time and 
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temperature are probably the explanation to contradictory results with respect to ROS 
generation.  
3.1.5 Inflammation 
Hypothermia attenuates inflammation by suppressing activating kinases of nuclear factor-
kappa B (NFkappaB). In a global cerebral ischemia model by bilateral carotid artery 
occlusion, microglial activation was observed and hypothermia decreased this activation as 
well as nuclear NFkappaB translocation and activation (Webster et al., 2009). NFkappaB is 
activated in cerebral ischemia, controlling the expression of inflammatory genes. In a study 
using middle cerebral artery occlusion by 2 h and hypothermia at 33 ºC, it was observed that 
the decrease in temperature decreased NFkappaB translocation and binding activity. 
Regulatory proteins such as IkappaB kinase were also affected decreasing its activity, 
suggesting that hypothermia exerts its protective effect by NFkappaB inhibition (Han et al., 
2003). 
3.2 Hypothermia and apoptosis signaling pathways 
3.2.1 Protein kinases activated by hypoxia 
In order to understand the protective mechanisms of hypothermia several efforts have been 
performed along years. It has been proposed that the mitochondria and the 
phosphatidylinositol 3-kinase (PI3-K)/Akt (protein kinase B) signaling pathway are 
determinant for neuronal survival controlling proapoptosis and antiapoptosis in ischemic 
neurons during stroke. Akt activity has been implicated in the endogenous neuroprotection 
observed by preconditioning (Miyawaki et al., 2008) and as part of the neuroprotective 
response to cerebral ischemia (Kamada et al., 2007). Several pharmacological efforts have 
been performed to target PI3-K/Akt pathway, since it is known that PI3-K/Akt downstream 
phosphorylated Bad and proline-rich Akt substrate survival signaling cascades are 
upregulated in surviving neurons in the ischemic brain (Chan et al., 2004).  
One of the most relevant efforts is the demonstration that PI3/Akt pathways are involved in 
neuroprotection by hypothermia. After the distal middle cerebral artery occlusion of rats 
using intra-ischemic hypothermia (30ºC), Zhao et al (2005) observed a reduction in infarct 
size and the improvement of neurological outcome up to two months. Relevant information 
was obtained from this work besides observed tissue protection and functional response: 1) 
decrease of Akt activity observed in normothermic animals after stroke was attenuated by 
hypothermia; 2) hypothermia improved phosphorylation and attenuates dephosphorylation 
of phosphatase and tensin homolog deleted on chromosome 10 (PTEN) and 
phosphoinositide-dependent protein kinase 1 (PDK1); 3) consequent to the observed tissue 
protection and the involvement of the Akt pathway, the inhibition of PI3K (an upstream 
activator of Akt) increases infarct size of hypothermic ischemic rats; 4) phosphorylation of 
forkhead transcription factor (FKHR) was improved by hypothermia attenuating its 
apoptotic effects, since dephosphorylated FKHR acts as a transcription factor increasing Bcl-
2 interacting mediator of cell death (Bim) and Fas ligand; 5) the nuclear translocation of the 
transcription factor P--catenin, observed in stroke normothermic rats was blocked by 
hypothermia in the penumbra, but not in the ischemic core, suggesting an important role of 
-catenin in stroke excitotoxicity (Zhao et al., 2005).  
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The same group evaluated the effect of hypothermia in the activation of a kinase implicated in 
neuroprotection in vitro, the epsilon protein kinase C (PKC), demonstrating that PKC 
preservation is an important component in the protective effect of hypothermia. Using the 
permanent distal middle cerebral artery occlusion plus 1 h of transient bilateral common 
carotid artery occlusion in normothermic (37ºC) and hypothermic (30ºC) rats, the neuronal full 
length PKC expression and localization was evaluated with inmmunofluorescence by 
confocal microscopy and western blot. Normothermic ischemic rats showed a decrease of 
PKC in the ischemic core at 4 h after common carotid artery release, hypothermia blocked this 
decrease. Hypothermia also affects cellular distribution. In non ischemic rats, PKC is in the 
cytoplasm of neurons. When cellular PKC distribution was determined, normothermic 
ischemic rats showed an PKC decrease in cytosol as well as in membranal fractions of the 
ischemic core, blocked by hypothermia. In the penumbra, the membranal PKC was decreased 
after the ischemic damage in normothermic rats and hypothermia blocked this decrease. Even 
hypothermia blocks PKC cleavage, inhibition of caspase-3 assays showed that this caspase is 
not involved in this process, suggesting the action of other proteases (Shimohata et al., 2007a). 
In contrast to PKC protective effect, delta protein kinase C (PKC) is involved in the tissue 
damage by ischemia. PKC activation depends on catalytic cleavage, phosphorylation and 
translocation to membranes. The inhibition of PKC activity using the specific inhibitor V1-1, 
decreased infarct size after transient cerebral ischemia (Brigth et al., 2004). The translocation to 
the nucleus and mitochondria, the caspase-3 dependent proteolytic cleavage to generate the 
PKC catalytic fragment (which increased in the membrane fraction, mitochondria, and 
nuclei); and the release of cytochrome c as earlier as 10 min after reperfusion, are processes 
triggered by common carotid artery occlusion. Hypothermia blocked all these processes; in 
fact, the subcellular translocation of the activated PKC was attenuated in the penumbra but 
not in the ischemic core (Shimohata et al., 2007b). All these protective effects were 
corroborated with the use of a specific PKC activator, RACK, in the hypothermic rats.  
Primary targets of ischemia-reperfusion injury are vascular endothelial cells through the 
stimulation of calcium overload, ROS generation and the triggering of inflammatory 
process, which in turn begin apoptotic programs. In order to determine mechanisms 
involved in hypothermia protection to ischemia and reperfusion damage, human umbilical 
endothelial cells were used. Using hypothermia (33ºC), a clear reduction in cell apoptosis 
induced by ischemia/reperfusion was observed. Characterization of this process showed 
that hypothermia reduces ischemia/reperfusion-induced apoptosis as observed by TUNEL, 
expression of activated caspase-3 and poly-ADP ribose polymerase (PARP). Hypothermia 
also reversed Fas/caspase 8 activation pathway and attenuated the Bax/Bcl-2 ratio 
compared with normothermic cells. Since JNK1/2 and p38 MAPK signaling pathways play 
an important role in oxidative stress-induced apoptosis, the effect of hypothermia in this 
pathway was studied, showing that hypothermia inhibits both extrinsic- and intrinsic-
dependent apoptotic pathways and activation of JNK1/2 activation via MKP-1 induction 
(Yang et al., 2009). 
3.2.2 Apoptotic proteins  
The decrease in apoptosis contributes in a significant manner to hypothermia protection. 
Ischemia and reperfusion have shown to increase the number of active caspase-3 
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immunoreactive nuclei, and hypothermia clearly reduced this induction (Kunimatsu et al., 
2001).  
Recently, Li & Wang (2011) used mild hypothermia (33 ºC) in rats subjected to middle 
cerebral artery occlusion and determined neurological impairment and the expression of 
Second Mitochondrion-derived Activator of Caspases (SMAC) as an index of cellular 
apoptosis. Mild hypothermia significantly improved the neurological deficit scores while 
results from protein and transcript expression of SMAC showed a significantly decrease, 
suggesting that mild hypothermia could be protecting the functions of cells by attenuating 
apoptotic death (Li & Wang, 2011). 
It has been previously shown that the pro-apoptotic protein SMAC/DIABLO expression is 
increased in cortex and hippocampus in transient cerebral ischemia as well as in ischemia-
reperfusion injury (Saito et al., 2003; Scarabelli & Stephanou, 2004; Siegelin et al., 2005). 
SMAC increases 3 h after cerebral ischemia with a peak at 24 h. Apparently, hypothermia 
could be down-regulating SMAC production attenuating caspases activation. Cell apoptosis 
via SMAC involve mitochondrial and death receptor pathways, inducing changes in 
mitochondrial membrane permeability and subsequently release membrane proteins, such 
as SMAC, into the cytoplasm. SMAC leads cells toward apoptosis through apoptosis-related 
protein. The prevention of loss of mitochondrial transmembrane potential, release of 
apoptotic proteins (citochrome c and apoptosis inducing factor [AIF]) and the activation of 
apoptotic proteins such as caspase 3, as well as the attenuation in the elevation of oxidative 
stress markers have been observed also in in vitro cells with hypothermia in a model of iron 
and ascorbic acid neurotoxicity (Hasegawa et al., 2009).  
Rats subjected to global cerebral ischemia with the four-vessel occlusion model with 
hypothermia (31-32 ºC) and hyperthermia (41-42ºC) confirmed the protective effects of 
hypothermia in the decrease of mortality rate (at 72 and 168 h post reperfusion), and in the 
increase of surviving neurons in hippocampus under hypothermic conditions. Hypothermia 
clearly reduced p53 and increased bcl-2 proteins reducing neuronal death. In addition 
hyperthermia had the opposite effect in the expression of both proteins (Zhang et al., 2010). 
3.3 Regulation of gene and protein expression 
Hypothermia induces changes in inflammatory, apoptotic and metabolic genes as the result 
of gene expression regulation.  
In general, it is considered that hypothermia downregulates gene expression. However, 
there are reports that show the upregulation of certain genes, particularly those involved in 
cell survival. The understanding of gene and protein expression as result of hypothermia in 
cerebral ischemia could lead to the possible therapeutic target genes or pathways regulated 
as a result of decreasing body temperature.  
Recently, an analysis of gene and protein expression using DNA microarrays and 
proteomics approach in a 2 h middle cerebral artery occlusion model and mild hypothermia 
(35ºC) has shown that it is possible to determine target molecules. The authors proposed 
that suppression of neuroinflammatory cascades MIP-3-CCR could contribute to the 
neuroprotective effects of hypothermia and also identified Hsp 70 as a neuroprotective 
factor stimulated by hypothermia (Shintani et al., 2010; Terao et al., 2009,).  
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3.3.1 Effect of hypothermia in proteins involved in gene expression 
The decrease in temperature and/or the decrease in oxygen concentration involve a series of 
events that modulate transcription and translation. Novel proteins have been discovered in 
the last decades. Here we show the role of cold inducible proteins and hypoxia inducible 
factor-1 as proteins that regulate the efficient transcription and translation of proteins in 
ischemia and ischemia/hypothermia events.  
3.3.1.1 Cold-inducible RNA-binding proteins 
Cold inducible proteins have the function to ensure the efficient translation of specific 
mRNAs at temperatures below the physiological standard. Hypothermia induces the 
synthesis of amino terminal consensus sequence RNA-binding domain proteins (CS-RBD). 
The “cold-inducible RNA-binding protein” (CIRP) is one of these proteins, and has been 
involved in protection as the result of hypothermia treatment in in vitro studies. CIRP 
regulates gene expression at translational level. It binds to the 5´-untranslated region (5´-
UTR) or 3´-UTR of specific transcripts, affecting translation and transcript stability (Lleonart, 
2010).  
CIRP has been proposed as a therapeutic target in cerebral ischemia by Liu et al (2010). They 
determined mRNA expression in hippocampus and cortex of rat brains subjected to 
hypothermia (30º), cerebral ischemia (by four vessel occlusion model of forebrain ischemia) 
and hypothermia plus cerebral ischemia by real time quantitative PCR analysis. mRNA 
CIRP expression was followed at 2, 6 and 24 h showing an increase in cortex after cerebral 
ischemia with a previous hypothermia treatment. In order to clarify the relationship 
between CIRP and energy metabolism, they determined lactate and piruvate concentrations, 
showing that CIRP has a neuroprotective effect in hypothermia; however, it is not related to 
energy metabolism.  
The contribution of CIRP to the neuroprotection observed by hypothermia has also been 
studied using MEMB5 cells, a neural stem cell line from mouse forebrain (Saito et al., 2010). 
These cells proliferate in the presence of epidermal growth factor (EGF). EGF deprivation at 
37 ºC results in apoptosis induction, as well as a decrease of the nestin neural stem cell 
marker and an increase of the astrocyte marker glial fibrillary acidic protein (GFAP). In 
contrast, MEMB5 cells at moderate hypothermia prevented apoptosis and decreased the 
observed GFAP expression of normothermic cells. This observation is important because it 
suggests that hypothermia prevents neural stem cells differentiation, and it has been 
hypothesized that the preservation of neural stem cells is one of the neuroprotective 
mechanisms of therapeutic hypothermia, since it could maintain the capability of cells to 
differentiate and proliferate after an ischemic event. CIRP mRNA and protein was increased 
in the MEB5 in hypothermic cells, a response according to previous observations showing 
that ischemia/reperfusion decreases CIRP mRNA (Xue et al., 1999) whereas hypothermia 
increases it in an in vivo cerebral ischemia model (Liu et al., 2010).  
The relevance of CIRP expression was confirmed using CIRP iRNA, increasing apoptosis in 
hypothermic cells without EGF. This result suggests that the induced CIRP plays the role of a 
survival factor in neural stem cells. The prevention of apoptosis observed with induced CIRP 
at hypothermia has been suggested to be the result of the activation of extracellular signal-
regulated kinase ERK (Artero-Castro et al., 2009; Sakurai et al., 2006; Schmitt et al., 2007).  
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3.3.1.2 Hypoxia inducible factor  
Hypoxia inducible factor is a transcription factor which binds to hypoxic response elements-
driven promoters of genes that mediate adaptive reactions to reduction in oxygen 
availability. Hypoxia inducible factor is regulated by oxygen accessibility and has been 
considered as a therapeutic target in cerebral ischemia (Aguilera et al., 2009). Recently it has 
been reported that persisting low temperature affects its stabilization and protein 
accumulation. Since the normal regulatory degradation processes of HIF are not affected by 
hypothermia, it has been hypothesized that probably hypothermia elevates intracellular 
oxygen tension by decreasing oxygen consumption, suppressing in turn HIF-1 alpha 
subunit induction. These results were obtained with different cell lines (T98G cells from 
human glioblastoma multiform, HeLa cells (derived from human cervical carcinoma) and 
Hep3B cells (derived from human hepatoma) as well as mice subjected to hypoxia and 
hypothermia (18ºC in a mouse incubator). The translation of HIF-1 alpha protein showed to 
be dependent on time exposure to hypothermia. The down-regulation of HIF protein 
expression observed with hypothermia has relevant implications in ischemia and 
hypothermia studies, since this transcription factor is a master regulator of the hypoxic 
response to oxygen decrease (Tanaka et al., 2010). 
3.3.2 Gene and protein expression in CA1 neurons as result of hypothermia 
Hippocampal CA1 layer is a region that presents a typical apoptosis cell death after ischemic 
damage. As a matter of fact , accumulating evidence has indicated that the postischemic 
DNA fragmentation in the hippocampal CA1 area in experimental ischemic models is a key 
phenomenon for the delayed neuronal death and is considered as apoptosis. Hypothermia 
has shown to protect CA1 neurons attenuating the down-regulation of GluR2 mRNA in a 
model of forebrain ischemia using two days of mild hypothermia induced after 1 h cerebral 
ischemia, suggesting that the observed attenuation and CA1 neurons protection responds to 
cooling (Colbourne et al., 2003). Another interesting protein is the -galactosidase-binding 
lectin Galectin-3, which has been observed expressed in experimental models of stroke 
(Walther et al., 2000; Yan et al., 2009) and increased in microgial cells in the hippocampal 
CA1 layer after a transient ischemic insult. Galectin-3 is a protein involved in apoptotic 
regulation, inflammation and cell differentiation and used as a marker of activated 
microglia. After 5 min of bilateral common carotid arteries of gerbils, galectin-3 expression 
was observed in microglial cells in CA1 region. Hypothermia (31ºC) prevents galectin-3 
expression suggesting that hypothermia protection occurs through the inhibition of 
microglial activation and probably by preventing neuronal death (Satoh et al., 2011). Even 
when galectin-3 has been considered apoptotic, its role as an inflammatory mediator in 
neonatal hypoxia ischemia injury through the modulation of the inflammatory response has 
been reported (Doverhag et al., 2010).  
4. Combined therapies 
The preservation of tissue and reduction of brain damage observed during hypothermia and 
the easiness to achieve and maintain low temperatures, constitute an attractive alternative 
against stroke. However, because of the complexity of the pathophysiological mechanisms 
involved in the ischemic cascade, it is common to observe the use of one or two drugs 
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besides hypothermia in the search of a neuroprotective compound capable of blocking the 
metabolic insult. Combination therapy is based in the extension of the therapeutic window 
of hypothermia using pharmacotherapy and establishes an interesting approach in 
hypothermia research. 
4.1 Hypothermia, tirilazad and magnesium 
The combined administration of the antioxidant tirilazad, magnesium and hypothermia has 
shown that the hypothermia protection increases with the use of pharmacotherapy, 
extending the therapeutic window of hypothermia treatment. Zausinger et al (2003) used 
hypothermia (2 h, 33ºC) at 0, 1, 3 and 5 h after transient focal ischemia induction combined 
with two administrations of tirilazad (3 mg/kg) and magnesium (1 mmol.L-1.kg-1) in 1 h 
intervals. Infarct volume was reduced by 74%, 49% and 45% when hypothermia was applied 
at 0, 1 and 3 h. No improvements were observed at 5 h. The same combination therapy was 
performed in a permanent ischemia with middle cerebral artery occlusion. Two h at 33 ºC 
hypothermia and two times of drug administration (30 min before and 1 h after middle 
cerebral artery occlusion) showed a 52 % infarct size reduction after 6 h occlusion. 
Interestingly, a separate group with 7 days of permanent middle cerebral artery occlusion 
was followed daily with neurological tests and body weight. Even high mortality ocurred in 
this group, neurological recovery was observed in survivor rats, as well as a decrease in 
infarct size (Schöller et al., 2004).  
Moderate hypothermia (30ºC) has shown higher protection than mild hypothermia (33ºC), 
however moderate hypothermia is associated with severe side effects. Nonetheless, the 
combined effect observed with mild hypothermia, magnesium and tirilazad showed a 
comparable protection with that observed using moderate hypothermia, suggesting that 
combination therapy could be a promising approach in clinical applications.  
4.2 Hypothermia and magnesium 
Combination therapy with magnesium has generated controversy, because magnesium 
treatment alone has shown to be ineffective in normothermic rats subjected to ischemia (Zhu 
et al., 2004, a and b). The quantification of infarct volumes at magnesium 360 or 720 
umol/kg in rats subjected to middle cerebral artery occlusion showed that the 360 umol/kg 
dose reduces the striatal infarct volume by 32 %. The authors observed that mild 
spontaneous hypothermia was responsible of the observed neuroprotective effect of 
magnesium (Campbell et al 2008a).  
The therapeutic time window of combined magnesium and mild hypothermia treatment 
was determined after permanent middle cerebral artery occlusion. The administration of a 
magnesium sulfate infusion (360 μmol/kg, then 120 μmol/kg/h) and mild hypothermia 
(35ºC) after 2, 4 or 6 h ischemia showed that combination therapy considerably reduced 
infarct volumes at 2 and 4 h but not at 6 h, supporting the use of combined therapy even at 
delayed hours after ischemia onset (Campbell et al 2008b). 
Although the controversy in the use of magnesium and hypothermia in cerebral ischemia 
exists, a lot of experimental evidence demonstrates its efficacy in laboratory studies and it is 
necessary to perform more clinical trials to translate this combinatorial therapy to clinical 
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use. Actually, combined mild hypothermia (35ºC) and magnesium is recognized as a 
neuroprotective treatment able to minimize ischemic damage, even in delayed treatments 
(Meloni et al., 2009). 
4.3 Hypothermia and citicoline 
Hypothermia has been combined with other compounds. One of them is citicoline, an 
endogenous compound that has shown to stabilize membrane function and reduce free 
radical generation during ischemia (Rao et al., 2000).  
Mild hypothermia combined with citicoline resulted in an additive effect in attenuating 
apoptosis in focal cerebral ischemia/reperfusion injury. Hypothermia (341ºC) during 
middle cerebral artery occlusion (2 h) followed by 24 h reperfusion was used in combination 
with 4000 mg/kg i.p. citicoline. Combined therapy with citicoline and hypothermia resulted 
in reduced apoptotic cell death before the development of the apoptosome, thus preventing 
apoptosis and neuronal damage. Bcl-2, caspases 3 and 9 as well as Bax proteins were 
immunohistochemistry tested, showing that the use of citicoline with hypothermia is more 
effective than citicoline or hypothermia used alone. A decrease in cerebral injury was 
observed and apparently, the tissue protection is due to the suppression of apoptotic 
processes (Sahin et al., 2010).  
4.4 Hypothermia and ginkgolides 
Despite the neuroprotective role of hypothermia, the combined use of hypothermia with 
protective compounds not always has a synergistic effect. This is the case of hypothermia 
and ginkgolides in astrocytes subjected to ischemia and reperfusion in which hypothermia 
attenuates, rather than enhances, the protective effect of ginkgolides on astrocytes from 
ischemia and reperfusion-induced injury. Co-treatment with different doses of ginkgolides 
at 32 and 28 ºC hypothermia during 24, 48 and 72 h before 24 h ischemia followed by 24 h 
reperfusion showed that the use of ginkgolides without hypothermia treatment had an 
improvement in cell viabilities and in anti-apoptotic properties, and this protective effects 
were not observed in the co-treatment (Fang et al., 2009).  
4.5 Hypothermia and xenon 
Xenon has been considered a great promise used as a neuroprotectant in in vivo and in vitro 
studies. Combined therapy with hypothermia in a neonatal rat hypoxia-ischemia model has 
shown that the combination of 50% xenon and hypothermia of 32°C has a protective effect 
in the restoration of long-term functional outcomes and global histopathology, showing that 
the combined xenon/hypothermia has a greater protection (Hobbs et al., 2008).  
5. Conclusion 
Despite all the efforts to develop pharmacological treatments to contend with cerebral 
ischemic damage, nowadays, there are no efficient treatments to deal with this pathology. 
Non-pharmacological treatments emerge as reasonable approaches to compete against 
ischemic damage.  
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Hypothermia has shown positive results in cardiac arrest and neonatal hypoxic ischemia 
and in patients with acute brain injury. However, there are no large clinical stroke studies 
that could assist in the comprehension of the hypothermia role in stroke. In laboratory 
studies, hypothermia is a consistent protective agent. The present chapter shows the 
contribution of hypothermia research in the last years to understand its participation during 
the different stages of the ischemic damage cascade. Blood brain barrier integrity, metabolic 
rate decrease, redox state changes, inflammatory, apoptotic, signalling and gene regulation 
are targets where hypothermia protection participates. Hypothermia is affected by diverse 
factors such as timing, duration and deepness. All these factors contribute to disparity in 
obtained results. However, it is clear that this research is necessary in order to determine the 
exact targets, the time when hypothermia begins and duration of hypothermia. 
Additionally, since brain ischemia is a multifactorial problem and hypothermia has 
demonstrated to decrease damage in several stages of the process, combination therapy is an 
alternative to improve treatments by the extension of the therapeutic time window of 
hypothermia protection.  
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